To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CDC73TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
289 supporting clones for gene CDC73 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DC396346 testis .a 1 to 571 1 to 571   tiling clone,   571/571
(100 %)
1 diff
(99.9 %id)
DC298135 adrenal gland .a 160 to 718 1 to 559       559/559
(100 %)
0 diff
(100 %id)
NM_024529.4   .a 160 to 6101 1 to 5942   RefSeq,   5942/5942
(100 %)
0 diff
(100 %id)
DC316188 amygdala .a 203 to 716 1 to 514       514/514
(100 %)
2 diff
(99.7 %id)
DN993175 brain, whole brain .a 213 to 793 1 to 581       581/581
(100 %)
5 diff
(99.2 %id)
BM471846 eye, retinoblastoma .a 214 to 1137 8 to 940       933/1052
(88 %)
34 diff
(96.8 %id)
DC391447 Spleen .a 226 to 784 1 to 563       563/565
(99 %)
6 diff
(99.0 %id)
BM849297 myeloma .a 233 to 799 1 to 567       567/567
(100 %)
2 diff
(99.7 %id)
DA557787   .a 234 to 782 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
DB033551 testis .a 234 to 781 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
BP310553 brain .a 236 to 827 1 to 592       592/592
(100 %)
0 diff
(100 %id)
DB004007 breast, tumor tissue .a 237 to 769 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
CX787680 human embryonic stem cells .a 242 to 1055 18 to 831       814/831
(97 %)
7 diff
(99.2 %id)
AK226038 cerebrum .a 263 to 2712 1 to 2450   AAA   2450/2450
(100 %)
4 diff
(99.9 %id)
BP213889 cerebrum .a 263 to 835 1 to 573       573/573
(100 %)
3 diff
(99.5 %id)
AK026969   .a 268 to 2710 1 to 2441   available from FLJ, AAA   2441/2441
(100 %)
9 diff
(99.7 %id)
BM471341 leiomyosarcoma, uterus .a 269 to 926 1 to 659       659/1184
(55 %)
24 diff
(98.0 %id)
BP240532 Liver .a 270 to 826 1 to 557       557/563
(98 %)
15 diff
(97.4 %id)
DA526349 brain .a 274 to 826 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
CB959565 Human Placenta, placenta .a 292 to 1024 6 to 750       745/790
(94 %)
29 diff
(96.4 %id)
AA157867 Pancreas .a 298 to 720 1 to 428       428/428
(100 %)
14 diff
(96.8 %id)
DC388265 small intestine .a 301 to 880 1 to 580       580/581
(99 %)
1 diff
(99.9 %id)
BC065037 Eye, retinoblastoma .a 323 to 2535 1 to 2213   available from MGC, AAA   2213/2213
(100 %)
0 diff
(100 %id)
BI912539 leukocyte .a 325 to 1021 1 to 707       707/712
(99 %)
15 diff
(97.9 %id)
BU167341 eye, retinoblastoma .a 325 to 1219 1 to 897       897/900
(99 %)
12 diff
(98.7 %id)
TI_57247401   .a 325 to 1021 35 to 741       707/746
(94 %)
21 diff
(97.2 %id)
AL547211 placenta, Placenta Cot 25-normalized .a 326 to 629 1 to 306       306/318
(96 %)
4 diff
(98.8 %id)
BP288803 lung .a 334 to 912 1 to 579       579/579
(100 %)
0 diff
(100 %id)
DA656457   .a 335 to 906 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA869143 Prostate .a 335 to 869 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
DA696652   .a 338 to 913 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DA669303 esophagus .a 339 to 908 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
CN311772 embryonic stem cells, DMSO-treated H9 cellline .a 344 to 862 1 to 520       520/520
(100 %)
1 diff
(99.9 %id)
DB058261 testis .a 360 to 909 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
CN311773 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 361 to 935 1 to 575       575/575
(100 %)
3 diff
(99.5 %id)
CN311771 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 363 to 923 6 to 566       561/566
(99 %)
6 diff
(99.0 %id)
DA472148   .a 363 to 1130 2 to 770   capped   769/794
(96 %)
8 diff
(99.0 %id)
AL704084 human skeletal muscle .a 367 to 789 1 to 423       423/423
(100 %)
0 diff
(100 %id)
BI063608 uterus_tumor .a 376 to 628 32 to 294       263/301
(87 %)
16 diff
(94.7 %id)
BG281852 melanotic melanoma, skin .a 376 to 1093 1 to 741       739/741
(99 %)
43 diff
(94.2 %id)
BC007325 Skin, melanotic melanoma. .a 377 to 1313 1 to 937   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 937/938
(99 %)
7 diff
(99.3 %id)
DA382761 thalamus .a 378 to 1006 2 to 631   capped   630/630
(100 %)
5 diff
(99.3 %id)
BI459257 testis .a 386 to 1129 1 to 741       741/742
(99 %)
8 diff
(99.0 %id)
DA265701 caudate nucleus .a 393 to 959 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
AF312865   .a 395 to 2712 1 to 2318   tiling clone,   2318/2318
(100 %)
0 diff
(100 %id)
BE727612 melanotic melanoma, skin .a 396 to 1072 1 to 688   available from MGC,   688/937
(73 %)
18 diff
(98.1 %id)
DA311028 hippocampus .a 400 to 964 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA738982   .a 400 to 962 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
AK314772   .a 402 to 1998 1 to 1597       1597/1597
(100 %)
0 diff
(100 %id)
EL735109 mixed .a 403 to 1013 1 to 611       611/611
(100 %)
1 diff
(99.9 %id)
BG339480 leiomyosarcoma cell line, uterus .a 403 to 981 1 to 581       581/785
(74 %)
11 diff
(98.6 %id)
DA725206   .a 403 to 969 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
TI_1948216058   .a 403 to 1261 139 to 995   fully sequenced, AAA   857/995
(86 %)
16 diff
(98.4 %id)
TI_1948216218   .a 403 to 1137 133 to 866   AAA   734/1409
(52 %)
10 diff
(99.3 %id)
TI_1948216376   .a 403 to 1200 136 to 932   fully sequenced,   797/932
(85 %)
10 diff
(99.0 %id)
TI_1948216533   .a 403 to 1261 133 to 991   fully sequenced,   859/991
(86 %)
9 diff
(99.1 %id)
DA946489 Spleen .a 432 to 1012 2 to 582   capped   581/581
(100 %)
1 diff
(99.9 %id)
BM786360 Ascites, stomach .a 435 to 1028 1 to 594       594/595
(99 %)
1 diff
(99.9 %id)
BQ927139 carcinoma, cell line, Prostate .a 447 to 1231 11 to 796       738/933
(79 %)
61 diff
(93.5 %id)
BE564677 bladder, carcinoma, cell line .a 492 to 981 1 to 490       490/892
(54 %)
9 diff
(99.0 %id)
AW245233.
matches multiple genes
lung, small cell carcinoma .a 503 to 950 10 to 457     Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base), also hits gene CSNK1E 448/457
(98 %)
6 diff
(98.7 %id)
AW250354 lung, small cell carcinoma .a 503 to 1020 10 to 527       518/527
(98 %)
6 diff
(98.9 %id)
BC011808 Lung, small cell carcinoma .a 503 to 2714 10 to 2221   AAA   2212/3564
(62 %)
5 diff
(99.9 %id)
BM464916 lymph, lymphoma, cell line .a 509 to 1137 1 to 629       629/1151
(54 %)
6 diff
(99.5 %id)
BU178011 melanotic melanoma, skin .a 551 to 1389 1 to 839       839/888
(94 %)
7 diff
(99.3 %id)
BX348777 Placenta Cot 25-normalized .a 567 to 1429 12 to 872       861/872
(98 %)
11 diff
(98.8 %id)
BC056410 Peripheral Nervous System, sympathetictrunk .a 625 to 1469 25 to 869   available from MGC, AAA   845/885
(95 %)
1 diff
(99.9 %id)
CN311770 embryonic stem cells, cell lines H1, H7, andH9 .a 627 to 1288 12 to 673       662/673
(98 %)
0 diff
(100 %id)
BU151819 sciatic nerve .a 640 to 1384 39 to 783   available from MGC,   745/901
(82 %)
7 diff
(99.3 %id)
AA314325 colon .a 645 to 1041 1 to 397       397/398
(99 %)
1 diff
(99.8 %id)
BM698263 eye, fetal eyes .a 667 to 1122 1 to 456       456/456
(100 %)
0 diff
(100 %id)
DA644172   .a 674 to 1247 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
BP194747 brain .a 714 to 1296 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
CD357597 Blood vessels - aorta, basilar and artery .a 723 to 1375 1 to 657       657/749
(87 %)
7 diff
(99.1 %id)
BC014351 Bladder, carcinoma .a 772 to 3011 4 to 2243   available from MGC, AAA   2240/2240
(100 %)
1 diff
(100.0 %id)
AL691599   .a 793 to 1432 1 to 641       641/644
(99 %)
2 diff
(99.7 %id)
BG030357 breast, mammary adenocarcinoma, cell line .a 814 to 1270 16 to 471       456/800
(57 %)
7 diff
(99.2 %id)
CB990446 Human Placenta, placenta .a 826 to 1372 21 to 566       546/753
(72 %)
8 diff
(99.0 %id)
CB959620 Human Placenta, placenta .a 826 to 1375 21 to 569       549/805
(68 %)
12 diff
(98.6 %id)
CB988225 Human Placenta, placenta .a 826 to 1554 21 to 753       733/801
(91 %)
14 diff
(98.3 %id)
EC451876 Prostate .a 837 to 916 82 to 3       80/91
(87 %)
0 diff
(100 %id)
EC466463 Prostate .a 837 to 916 83 to 4       80/92
(86 %)
0 diff
(100 %id)
EC498186 Prostate .a 837 to 929 92 to 1       92/99
(92 %)
2 diff
(98.0 %id)
DA368620 subthalamic nucleus .a 843 to 1424 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
CF140142 CNCAP(3)T-225 cell line, Prostate .a 852 to 1387 8 to 543       536/546
(98 %)
14 diff
(97.5 %id)
TI_154170493   .a 852 to 1387 80 to 615       536/1016
(52 %)
8 diff
(99.3 %id)
TI_57171761   .a 857 to 1695 66 to 910       845/910
(92 %)
20 diff
(97.9 %id)
BI827942 brain, medulla .a 860 to 1695 1 to 842       842/842
(100 %)
14 diff
(98.4 %id)
DB202885 trachea .a 889 to 1463 2 to 577   capped   576/577
(99 %)
3 diff
(99.5 %id)
AA333812   .a 896 to 1143 1 to 250       250/250
(100 %)
3 diff
(98.8 %id)
CF121265 CNCAP(3)T-225 cell line, Prostate .a 927 to 1643 1 to 713       713/713
(100 %)
8 diff
(98.9 %id)
CV028767 mixed .a 931 to 1560 1 to 630       630/630
(100 %)
0 diff
(100 %id)
TI_1948122786   .a 931 to 1499 123 to 691   fully sequenced,   569/691
(82 %)
6 diff
(99.2 %id)
TI_1948122924   .a 931 to 1463 125 to 656   fully sequenced,   532/656
(81 %)
8 diff
(98.8 %id)
TI_1948123077   .a 931 to 1405 124 to 598   fully sequenced,   475/598
(79 %)
6 diff
(99.0 %id)
TI_1948123224   .a 931 to 1499 124 to 692   fully sequenced,   569/692
(82 %)
6 diff
(99.2 %id)
TI_154180281   .a 933 to 1731 74 to 867       794/796
(99 %)
9 diff
(98.9 %id)
BI909331 leukocyte .a 937 to 1687 1 to 748       748/749
(99 %)
10 diff
(98.7 %id)
TI_57233898   .a 937 to 1687 31 to 778       748/779
(96 %)
14 diff
(98.3 %id)
BQ218997 leiomyosarcoma, uterus .a 946 to 1905 12 to 973       962/1014
(94 %)
31 diff
(97.0 %id)
AA384726 thyroid gland .a 964 to 1277 1 to 314       314/314
(100 %)
2 diff
(99.4 %id)
BF511397   .a 978 to 1290 331 to 1       352/337
(104 %)
59 diff
(82.5 %id)
BF511249   .a 978 to 1290 331 to 1       352/337
(104 %)
59 diff
(82.5 %id)
BQ224042 melanotic melanoma, skin .a 981 to 1709 1 to 740       738/845
(87 %)
20 diff
(97.7 %id)
AA384586 thyroid gland .a 1087 to 1384 1 to 299       299/318
(94 %)
8 diff
(97.5 %id)
AW966479   .a 1088 to 1748 1 to 661       661/664
(99 %)
16 diff
(97.6 %id)
TI_1948216219   .a 1134 to 2005 990 to 114       877/1204
(72 %)
17 diff
(98.6 %id)
BX329041 Placenta Cot 25-normalized .a 1135 to 1823 683 to 1       683/683
(100 %)
10 diff
(98.6 %id)
CB149531 Liver .a 1139 to 1730 1 to 591       591/591
(100 %)
4 diff
(99.4 %id)
CN311766 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1159 to 1459 1 to 301       301/301
(100 %)
0 diff
(100 %id)
TI_1948216377   .a 1170 to 2005 952 to 114   fully sequenced,   839/952
(88 %)
13 diff
(98.7 %id)
BG929275 cartilage .a 1174 to 1725 86 to 637       552/569
(97 %)
6 diff
(99.0 %id)
TI_1948216059   .a 1200 to 2005 918 to 113   fully sequenced,   806/918
(87 %)
5 diff
(99.5 %id)
TI_1948216534   .a 1231 to 2005 891 to 116   fully sequenced,   776/891
(87 %)
6 diff
(99.4 %id)
BF742908 breast .a 1253 to 1510 1 to 257       257/262
(98 %)
6 diff
(97.8 %id)
TI_1948123078   .a 1344 to 2005 776 to 115   fully sequenced,   662/776
(85 %)
6 diff
(99.3 %id)
BU902623 leiomyosarcoma, uterus .a 1348 to 2258 1 to 923       923/925
(99 %)
15 diff
(98.4 %id)
TI_57218525   .a 1372 to 2168 35 to 834       800/839
(95 %)
11 diff
(98.7 %id)
BG611612 adenocarcinoma, Prostate .a 1374 to 1998 1 to 625       625/626
(99 %)
9 diff
(98.6 %id)
BG192263   .a 1376 to 1698 1 to 323       323/323
(100 %)
3 diff
(99.1 %id)
BG205114   .a 1376 to 2198 1 to 823       823/826
(99 %)
8 diff
(99.1 %id)
BG208691   .a 1376 to 2168 1 to 789       789/790
(99 %)
29 diff
(96.4 %id)
BM146521 leukopheresis .a 1378 to 1866 1 to 490       490/497
(98 %)
7 diff
(98.6 %id)
BM146522 leukopheresis .a 1378 to 1895 1 to 518       518/518
(100 %)
0 diff
(100 %id)
TI_1948122925   .a 1402 to 2005 721 to 118   fully sequenced,   604/721
(83 %)
5 diff
(99.4 %id)
H72423 liver and spleen .a 1430 to 1800 372 to 1     Submitted on the opposite strand 372/484
(76 %)
1 diff
(99.8 %id)
TI_1948122787   .a 1438 to 2005 684 to 117   fully sequenced,   568/684
(83 %)
5 diff
(99.3 %id)
TI_1948123225   .a 1438 to 2005 681 to 114   fully sequenced,   568/681
(83 %)
5 diff
(99.3 %id)
AW382198 head_neck .a 1448 to 1920 476 to 1       476/476
(100 %)
17 diff
(96.5 %id)
CF127011 Chondrosarcoma Lung Metastasis cell lines, lung .a 1452 to 2182 1 to 731       731/731
(100 %)
1 diff
(99.9 %id)
TI_154190106   .a 1452 to 2326 51 to 916       866/998
(86 %)
17 diff
(98.3 %id)
CN311769 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1462 to 2052 1 to 591       591/591
(100 %)
4 diff
(99.4 %id)
DN918365   .a 1462 to 2028 20 to 586       567/586
(96 %)
1 diff
(99.9 %id)
BG900779 cartilage .a 1472 to 1924 45 to 498       454/498
(91 %)
16 diff
(96.8 %id)
BE185286 head_neck .a 1485 to 1823 15 to 353       339/379
(89 %)
24 diff
(93.7 %id)
BE565681 bladder, carcinoma, cell line .a 1488 to 1963 1 to 480       482/736
(65 %)
22 diff
(97.1 %id)
W78960 liver and spleen .a 1489 to 1932 1 to 450       450/463
(97 %)
6 diff
(98.8 %id)
CD643851 Embryonic Stem cells .a 1527 to 2315 6 to 777       772/821
(94 %)
31 diff
(96.3 %id)
AW371720 breast .a 1529 to 1943 422 to 10       413/423
(97 %)
3 diff
(99.3 %id)
BM557981 duodenal adenocarcinoma, cell line, small intestine .a 1532 to 2298 1 to 775       775/973
(79 %)
25 diff
(97.5 %id)
AA331541 Embryo, 8 weeks .a 1533 to 1785 1 to 254       254/254
(100 %)
1 diff
(99.7 %id)
AA331747 Embryo, 8 weeks .a 1533 to 1752 1 to 220       220/220
(100 %)
0 diff
(100 %id)
AW582549 stomach .a 1553 to 1783 1 to 230       230/233
(98 %)
12 diff
(94.9 %id)
AW609900 stomach .a 1559 to 1785 11 to 235       225/254
(88 %)
12 diff
(95.3 %id)
BG205223   .a 1559 to 2288 736 to 9     Submitted on the opposite strand 728/841
(86 %)
8 diff
(99.1 %id)
AW802770 uterus .a 1566 to 1819 1 to 254       254/267
(95 %)
5 diff
(98.2 %id)
TI_149281980   .a 1583 to 2293 797 to 88   AAA   710/711
(99 %)
2 diff
(99.8 %id)
T70837 liver and spleen .a 1602 to 1784 1 to 181       181/188
(96 %)
4 diff
(97.9 %id)
BF331517 breast .a 1611 to 1793 1 to 184       184/207
(88 %)
5 diff
(97.6 %id)
TI_153992022   .a 1617 to 2420 875 to 84   AAA   792/929
(85 %)
18 diff
(98.1 %id)
BU679730 lung .a 1621 to 2293 691 to 19   AAA   673/673
(100 %)
1 diff
(99.9 %id)
BP205132 coronary artery .a 1625 to 2200 1 to 583       583/583
(100 %)
39 diff
(93.4 %id)
AL704704 human skeletal muscle .a 1718 to 2171 8 to 461       454/461
(98 %)
6 diff
(98.7 %id)
AW207713   .a 1790 to 2420 646 to 18   AAA   629/629
(100 %)
2 diff
(99.7 %id)
BE042761 colon, moderately-differentiated adenocarcinoma .a 1819 to 2300 482 to 1       482/482
(100 %)
0 diff
(100 %id)
AL547172 placenta, Placenta Cot 25-normalized .a 1820 to 2263 446 to 1       446/452
(98 %)
9 diff
(98.1 %id)
AW029389 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 1826 to 2295 470 to 1       470/470
(100 %)
0 diff
(100 %id)
AA425171   .a 1839 to 2257 1 to 419       419/419
(100 %)
1 diff
(99.8 %id)
AA450190   .a 1839 to 2291 1 to 453       453/453
(100 %)
0 diff
(100 %id)
BI089932 cervix .a 1863 to 2717 1 to 851       851/863
(98 %)
12 diff
(98.7 %id)
BQ417005 Pancreas, Purified pancreatic islet .a 1866 to 2461 1 to 596       596/596
(100 %)
0 diff
(100 %id)
AI023982 parathyroid gland, parathyroid tumor .a 1869 to 2300 444 to 13   AAA   432/432
(100 %)
0 diff
(100 %id)
CK826056 Pancreas, Purified pancreatic islet .a 1894 to 2478 1 to 585     Submitted on the opposite strand 585/585
(100 %)
0 diff
(100 %id)
CN311774 embryonic stem cells, cell lines H1, H7, andH9 .a 1910 to 2508 1 to 598       598/598
(100 %)
1 diff
(99.9 %id)
AW236326 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .a 1948 to 2426 479 to 1       479/479
(100 %)
0 diff
(100 %id)
BG206838   .a 1957 to 2545 1 to 585   AAA   585/585
(100 %)
17 diff
(97.1 %id)
ES315893 melanoma cell line .a 1959 to 2156 39 to 237       199/237
(83 %)
6 diff
(97.5 %id)
BU569400 testis .a 1966 to 2716 1 to 760       760/782
(97 %)
20 diff
(97.5 %id)
DA735852   .a 1974 to 2775 2 to 805   capped   804/804
(100 %)
10 diff
(98.8 %id)
TI_149293696   .a 1979 to 2710 804 to 82   AAA   723/925
(78 %)
9 diff
(99.1 %id)
AI183810   .a 1994 to 2296 303 to 1       303/303
(100 %)
0 diff
(100 %id)
BQ722675 sympathetic trunk .a 2000 to 2879 1 to 895       895/929
(96 %)
29 diff
(96.9 %id)
BM975231 lung .a 2017 to 2710 708 to 19   AAA   690/691
(99 %)
4 diff
(99.5 %id)
BC013075 Placenta, choriocarcinoma .a 2070 to 2715 1 to 647   available from MGC, AAA   647/647
(100 %)
1 diff
(99.9 %id)
EH345875   .a 2081 to 2156 1 to 76       76/76
(100 %)
0 diff
(100 %id)
AA357632 Prostate .a 2090 to 2359 1 to 271       271/271
(100 %)
3 diff
(98.9 %id)
BE537890 cervix .a 2092 to 2707 1 to 613       613/615
(99 %)
8 diff
(98.7 %id)
AI810396 Prostate .a 2144 to 2714 576 to 6       571/576
(99 %)
0 diff
(100 %id)
BM463881 melanotic melanoma, skin .a 2147 to 2989 18 to 863       846/1098
(77 %)
23 diff
(98.0 %id)
AW958846   .a 2161 to 2521 1 to 361   AAA   361/361
(100 %)
0 diff
(100 %id)
DB314776   .a 2188 to 2710 524 to 1       524/524
(100 %)
1 diff
(99.9 %id)
AI302169 2 pooled tumors (clear cell type), Kidney .a 2192 to 2714 524 to 2       523/524
(99 %)
0 diff
(100 %id)
DB143991 thymus .a 2195 to 2679 2 to 486   capped   485/485
(100 %)
0 diff
(100 %id)
AA526956 breast .a 2206 to 2710 502 to 1       502/518
(96 %)
20 diff
(96.2 %id)
BX641688   .a 2223 to 2755 1 to 532       532/532
(100 %)
2 diff
(99.7 %id)
EC581418 Prostate .a 2227 to 2339 7 to 117       111/117
(94 %)
6 diff
(94.9 %id)
AI701334 Prostate .a 2267 to 2674 408 to 1       408/408
(100 %)
0 diff
(100 %id)
AW071139 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary .a 2275 to 2710 449 to 14   AAA   436/436
(100 %)
2 diff
(99.6 %id)
AI263326   .a 2279 to 2714 441 to 6       436/441
(98 %)
0 diff
(100 %id)
AI983639 adenocarcinoma, Pancreas .a 2286 to 2714 433 to 5       429/433
(99 %)
0 diff
(100 %id)
AA157568 Pancreas .a 2295 to 2712 418 to 1       418/418
(100 %)
1 diff
(99.8 %id)
FN105754 breast carcinoma .a 2298 to 2355 57 to 1     Submitted on the opposite strand 57/57
(100 %)
1 diff
(98.3 %id)
W80454 liver and spleen .a 2303 to 2710 420 to 3       418/420
(99 %)
0 diff
(100 %id)
N70430 liver and spleen .a 2318 to 2710 402 to 2       401/407
(98 %)
0 diff
(100 %id)
AA479929   .a 2324 to 2608 292 to 8       285/292
(97 %)
0 diff
(100 %id)
AA450124   .a 2324 to 2607 284 to 1       284/284
(100 %)
0 diff
(100 %id)
BG533967 lung .a 2330 to 3026 1 to 696       696/696
(100 %)
9 diff
(98.8 %id)
AI079467 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2331 to 2714 389 to 6       384/389
(98 %)
0 diff
(100 %id)
BM667551 eye, fetal eyes .a 2333 to 2710 396 to 19   AAA   378/378
(100 %)
2 diff
(99.5 %id)
AI422655 Prostate .a 2344 to 2626 283 to 1       283/283
(100 %)
0 diff
(100 %id)
AA626156   .a 2351 to 2719 374 to 4       371/374
(99 %)
0 diff
(100 %id)
BM463202 embryonal carcinoma, cell line, testis .a 2370 to 3327 1 to 968       968/968
(100 %)
13 diff
(98.7 %id)
EC578823 Prostate .a 2411 to 2509 1 to 97       97/102
(95 %)
3 diff
(97.1 %id)
T70566 liver and spleen .a 2419 to 2700 283 to 1       283/287
(98 %)
1 diff
(99.7 %id)
AV733287 pheochromocytoma .a 2426 to 2712 1 to 288   AAA   288/288
(100 %)
2 diff
(99.4 %id)
DN918364   .a 2428 to 3030 605 to 3       603/605
(99 %)
0 diff
(100 %id)
BF030000 hypernephroma, Kidney .a 2438 to 3138 1 to 693       693/719
(96 %)
25 diff
(96.6 %id)
AW009098 colon .a 2439 to 2726 287 to 1       287/287
(100 %)
1 diff
(99.7 %id)
AI081752 breast .a 2475 to 2709 235 to 1       235/235
(100 %)
0 diff
(100 %id)
AI560564 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 2504 to 2710 209 to 1       209/210
(99 %)
2 diff
(99.1 %id)
BM564681 eye, retinoblastoma .a 2507 to 2710 1 to 204   AAA   204/204
(100 %)
0 diff
(100 %id)
AW273396 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 2511 to 3034 528 to 5       524/528
(99 %)
0 diff
(100 %id)
BP396507 pancreatic islet .a 2522 to 2710 1 to 189     Submitted on the opposite strand 189/189
(100 %)
0 diff
(100 %id)
D20574   .a 2528 to 2623 1 to 96     Submitted on the opposite strand 96/98
(97 %)
1 diff
(99.0 %id)
AW468924 pooled .a 2614 to 3038 430 to 2       429/430
(99 %)
0 diff
(100 %id)
BU428536 lymph .a 2622 to 3212 1 to 591       591/591
(100 %)
4 diff
(99.4 %id)
TI_154149357   .a 2628 to 3400 77 to 841   tiling clone,   765/790
(96 %)
17 diff
(97.9 %id)
BF741669 bocio_tumor .a 2630 to 2873 1 to 245       245/245
(100 %)
5 diff
(98.0 %id)
BG220711   .a 2717 to 2956 243 to 4     Submitted on the opposite strand 240/257
(93 %)
0 diff
(100 %id)
BG209284   .a 2719 to 2952 240 to 7     Submitted on the opposite strand 234/256
(91 %)
0 diff
(100 %id)
AI620330 Prostate .a 2741 to 2928 1 to 188     Submitted on the opposite strand 188/188
(100 %)
0 diff
(100 %id)
FN089071 breast carcinoma .a 2757 to 2872 113 to 1     Submitted on the opposite strand 113/117
(96 %)
3 diff
(97.5 %id)
CV575481 cornea, eye .a 2848 to 3471 1 to 624       624/624
(100 %)
0 diff
(100 %id)
AW664388 2 pooled high-grade transitional celltumors, genitourinary tract .a 3131 to 3631 512 to 12   tiling clone, AAA   501/501
(100 %)
0 diff
(100 %id)
AA282613 germinal center B cell .a 3142 to 3552 1 to 409       409/409
(100 %)
1 diff
(99.8 %id)
AL691915   .a 3179 to 3581 1 to 401       401/401
(100 %)
3 diff
(99.3 %id)
GD150987   .a 3363 to 3425 63 to 1     Submitted on the opposite strand 63/64
(98 %)
1 diff
(98.5 %id)
DB368208   .a 3495 to 4034 544 to 3       542/544
(99 %)
0 diff
(100 %id)
DA645408   .a 3603 to 4177 2 to 577   tiling clone, capped   576/576
(100 %)
1 diff
(99.9 %id)
BU191887 embryonal carcinoma, cell line, testis .a 3632 to 4413 1 to 786   tiling clone,   786/904
(86 %)
9 diff
(99.1 %id)
H16113 breast .a 3761 to 4073 1 to 313       313/364
(85 %)
4 diff
(99.0 %id)
TI_149285393   .a 3857 to 4672 905 to 92   AAA   814/1141
(71 %)
31 diff
(97.3 %id)
AA194053 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3867 to 4465 1 to 597       597/599
(99 %)
12 diff
(98.0 %id)
BF671545 muscle (skeletal) .a 3941 to 4603 1 to 659       659/659
(100 %)
6 diff
(99.1 %id)
BG122248 adenocarcinoma, cell line, Liver .a 3944 to 4684 1 to 745       745/796
(93 %)
20 diff
(97.5 %id)
TI_151774906   .a 3944 to 4568 110 to 744       635/942
(67 %)
28 diff
(97.1 %id)
AA156813.
matches multiple genes
uterus .a 4023 to 4618 1 to 587     also hits gene BET1 587/628
(93 %)
7 diff
(98.9 %id)
AA101989 uterus .a 4034 to 4231 1 to 200       200/200
(100 %)
4 diff
(98.0 %id)
AA133251 uterus .a 4036 to 4104 1 to 75   fully sequenced,   75/75
(100 %)
0 diff
(100 %id)
T39221 lung .a 4065 to 4327 1 to 263       263/263
(100 %)
5 diff
(98.1 %id)
AA129756 uterus .a 4074 to 4611 537 to 1   fully sequenced,   537/537
(100 %)
6 diff
(98.9 %id)
BU680834 lung .a 4082 to 4672 609 to 19   AAA   591/591
(100 %)
4 diff
(99.4 %id)
AI458080 pooled .a 4107 to 4672 582 to 17   AAA   566/566
(100 %)
0 diff
(100 %id)
AA156718.
matches multiple genes
uterus .a 4111 to 4664 561 to 9     also hits gene BET1 553/572
(96 %)
0 diff
(100 %id)
BG622831 placenta .a 4150 to 4843 1 to 698       698/765
(91 %)
34 diff
(95.6 %id)
CD652820 Embryonic Stem cells .a 4202 to 4949 12 to 749   tiling clone,   738/814
(90 %)
12 diff
(98.6 %id)
AW021970 cochlea, ear .a 4248 to 4690 1 to 443       443/443
(100 %)
3 diff
(99.4 %id)
AW184037 pooled .a 4255 to 4665 421 to 11   AAA   411/411
(100 %)
0 diff
(100 %id)
AA099552 uterus .a 4262 to 4664 416 to 9       408/416
(98 %)
0 diff
(100 %id)
AW192020 adenocarcinoma, Pancreas .a 4262 to 4662 406 to 6       401/406
(98 %)
0 diff
(100 %id)
AI984588 malignant melanoma, metastatic to lymphnode, skin .a 4315 to 4659 345 to 1       345/345
(100 %)
1 diff
(99.8 %id)
FN051071 breast carcinoma .a 4323 to 4390 66 to 1     Submitted on the opposite strand 66/67
(98 %)
2 diff
(97.1 %id)
FN083815 breast carcinoma .a 4345 to 4443 101 to 1     Submitted on the opposite strand 101/102
(99 %)
3 diff
(97.1 %id)
H15812 breast .a 4403 to 4672 270 to 1       270/270
(100 %)
1 diff
(99.7 %id)
Z36734   .a 4425 to 4754 1 to 332       332/332
(100 %)
3 diff
(99.1 %id)
AA447464   .a 4469 to 4802 1 to 334       334/334
(100 %)
0 diff
(100 %id)
EH313577   .a 4552 to 4640 1 to 89       89/89
(100 %)
3 diff
(96.7 %id)
AL044007 testis .a 4663 to 5182 535 to 16   AAA   520/520
(100 %)
0 diff
(100 %id)
AW976559   .a 4664 to 5181 517 to 1     Submitted on the opposite strand 517/517
(100 %)
11 diff
(97.9 %id)
AI004942   .a 4664 to 5185 522 to 1       522/522
(100 %)
3 diff
(99.5 %id)
CB053020 leiomyosarcoma, soft tissue .a 4688 to 5016 20 to 347       328/347
(94 %)
6 diff
(98.3 %id)
AA938667 germinal center B cell .a 4717 to 5187 475 to 5   tiling clone,   471/475
(99 %)
0 diff
(100 %id)
AI915568 pooled .a 4724 to 5181 458 to 1       458/458
(100 %)
1 diff
(99.8 %id)
BF435558 sciatic nerve .a 4734 to 5182 465 to 17   AAA   449/449
(100 %)
2 diff
(99.6 %id)
C06077   .a 4758 to 5187 431 to 3       429/435
(98 %)
0 diff
(100 %id)
AA744621 germinal center B cell .a 4760 to 5187 432 to 5       428/432
(99 %)
0 diff
(100 %id)
AI015099   .a 4822 to 5186 365 to 1       365/365
(100 %)
1 diff
(99.8 %id)
AW069095 bone marrow stroma .a 4855 to 5182 346 to 19   AAA   328/328
(100 %)
0 diff
(100 %id)
CN305147 embryonic stem cells, DMSO-treated H9 cellline .a 4895 to 5266 1 to 372       372/372
(100 %)
5 diff
(98.7 %id)
AI612739 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 4952 to 5179 245 to 18   AAA   228/228
(100 %)
0 diff
(100 %id)
AA446658   .a 4968 to 5186 219 to 1       219/219
(100 %)
0 diff
(100 %id)
GD158364   .a 5016 to 5187 1 to 172       172/174
(98 %)
2 diff
(98.9 %id)
T92974.
matches multiple genes
lung .a 5024 to 5331 1 to 320     also hits gene zarbar 320/378
(84 %)
13 diff
(96.6 %id)
BQ722060 sympathetic trunk .a 5080 to 5914 1 to 842   tiling clone,   842/854
(98 %)
11 diff
(98.8 %id)
BJ997679 Wilms tumor .a 5169 to 5543 1 to 375   fully sequenced,   375/375
(100 %)
1 diff
(99.8 %id)
BI869980 adenocarcinoma, cell line, Liver .a 5231 to 5932 27 to 730       704/731
(96 %)
20 diff
(97.3 %id)
BI870067 adenocarcinoma, cell line, Liver .a 5231 to 5886 27 to 683       657/685
(95 %)
12 diff
(98.3 %id)
TI_57229392   .a 5231 to 5886 98 to 754       657/685
(95 %)
12 diff
(98.3 %id)
TI_57229570   .a 5231 to 5932 110 to 813       704/731
(96 %)
20 diff
(97.3 %id)
CB243902 Human Lung Epithelial cells, lung .a 5415 to 6104 1 to 690   tiling clone, AAA Submitted on the opposite strand 690/692
(99 %)
8 diff
(98.9 %id)
BJ997680 Wilms tumor .a 5513 to 6052 540 to 1   fully sequenced,   540/540
(100 %)
0 diff
(100 %id)
DB321416   .a 5564 to 6096 533 to 1   tiling clone,   533/533
(100 %)
0 diff
(100 %id)
AA248828   .a 5612 to 5845 1 to 232       232/235
(98 %)
6 diff
(97.5 %id)
BF678946 Prostate .a 5613 to 6089 1 to 477   AAA   477/477
(100 %)
1 diff
(99.8 %id)
AI638120 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 5695 to 6096 428 to 27   AAA   402/402
(100 %)
4 diff
(99.1 %id)
AI554251 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 5757 to 5946 192 to 3       190/192
(98 %)
0 diff
(100 %id)
EH319248   .a 5782 to 5837 1 to 56       56/69
(81 %)
0 diff
(100 %id)
DA389415 thalamus .b 1 to 529 2 to 530   tiling clone, capped   529/529
(100 %)
1 diff
(99.9 %id)
DA221353 brain .b 296 to 819 2 to 526   capped   525/530
(99 %)
4 diff
(99.3 %id)
BI754402 brain .b 310 to 1108 1 to 802 exact tiling clone,   802/807
(99 %)
5 diff
(99.4 %id)
DA471560   .c 1 to 566 2 to 567 I46F tiling clone, capped   566/566
(100 %)
1 diff
(99.9 %id)
BE748341 bone marrow, from acute myelogenous leukemia .d 1 to 596 1 to 593 exact tiling clone,   593/767
(77 %)
6 diff
(99.3 %id)
BE748813 bone marrow, from acute myelogenous leukemia .d 1 to 527 563 to 37 exact tiling clone,   527/563
(93 %)
0 diff
(100 %id)
R35556 placenta .e 1 to 275 1 to 283 exact     283/345
(82 %)
9 diff
(97.4 %id)
R77682 placenta .e 1 to 253 1 to 253 exact tiling clone,   253/253
(100 %)
0 diff
(100 %id)
BX106205 placenta .e 2 to 765 1 to 764 exact tiling clone,   764/764
(100 %)
0 diff
(100 %id)
R34229 placenta .e 666 to 992 334 to 1       334/341
(97 %)
8 diff
(97.7 %id)
R77683 placenta .e 722 to 992 273 to 1   tiling clone,   273/273
(100 %)
2 diff
(99.3 %id)
BU155114 bone marrow, from acute myelogenous leukemia .f 1 to 725 1 to 731 S20L tiling clone,   730/797
(91 %)
18 diff
(97.8 %id)
DB251663 uterus .g 1 to 558 2 to 559   tiling clone, capped   558/558
(100 %)
0 diff
(100 %id)
BE079299 breast .h-u 1 to 268 1 to 268 exact tiling clone,   268/268
(100 %)
0 diff
(100 %id)
BE696298 colon Gene CDC73, variant not shown         This clone was ignored    
AL704662 human skeletal muscle Gene CDC73, variant not shown         This clone was ignored    
BX951677   Gene CDC73, variant not shown              
AL701114 human skeletal muscle Gene CDC73, variant not shown              
AA296752 Bone Gene CDC73, variant not shown         This clone was ignored    
BP342068 stomach mucosa Gene CDC73, variant not shown         Suspected internal deletion, this clone was ignored    
BX476349   Gene CDC73, variant not shown              
AK300929 small intestine Gene CDC73, variant not shown         Suspected internal deletion, this clone was ignored    
DA880475 Prostate Gene CDC73, variant not shown       capped This clone was ignored    
DB330314 Prostate Gene CDC73, variant not shown         This clone was ignored    
DC374781 brain Gene CDC73, variant not shown         Suspected internal deletion, this clone was ignored    
DC376230 brain Gene CDC73, variant not shown         Suspected internal deletion, this clone was ignored    
DB220707 trachea Gene CDC73, variant not shown       capped      
DB349389 trachea Gene CDC73, variant not shown              
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI